Literature DB >> 13619027

The discovery of dicumarol and its sequels.

K P LINK.   

Abstract

Entities:  

Keywords:  BISHYDROXYCOUMARIN

Mesh：

Substances：

Year:  1959        PMID： 13619027     DOI： 10.1161/01.cir.19.1.97

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  40 in total

1.  STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.

Authors:  R A O'REILLY; P M AGGELER; L S LEONG
Journal:  J Clin Invest       Date:  1963-10       Impact factor: 14.808

2.  Blood at 70: its roots in the history of hematology and its birth.

Authors:  Barry S Coller
Journal:  Blood       Date:  2015-12-10       Impact factor: 22.113

Review 3.  Some Important Milestones in the Field of Blood Clotting.

Authors:  Russell F Doolittle
Journal:  J Innate Immun       Date:  2015-12-15       Impact factor: 7.349

Review 4.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  [Role of vitamin K antagonists from a hepatologist's point of view].

Authors:  G Kneiseler; A Canbay; G Gerken
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

Review 6.  The new oral anticoagulants: results of clinical trials and practical applications.

Authors:  Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

Review 7.  Warfarin: history, tautomerism and activity.

Authors:  William R Porter
Journal:  J Comput Aided Mol Des       Date:  2010-03-30       Impact factor: 3.686

8.  Anticoagulant therapy.

Authors:  J M Teitel
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

Review 9.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

10.  Warfarin and vitamin K compete for binding to Phe55 in human VKOR.

Authors:  Katrin J Czogalla; Arijit Biswas; Klara Höning; Veit Hornung; Kerstin Liphardt; Matthias Watzka; Johannes Oldenburg
Journal:  Nat Struct Mol Biol       Date:  2016-12-12       Impact factor: 15.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.